Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Brentuximab vedotin联合化疗治疗CD30阳性外周T细胞淋巴瘤(ECHELON-2):一项全球性、双盲、随机、3期临床试验
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(18)32984-2
Horwitz, Steven; O'Connor, Owen A; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J; Yuen, Sam; Iyer, Swaminathan; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz
T细胞
淋巴瘤
CD30
CD3
T细胞
细胞生物学
免疫/内分泌